Increasing quality of life and reducing HIV burden: The PATH+ intervention

AIDS and Behavior

Volumn 18, Issue 4, 2014, Pages 716-725

  Blank, Michael B ^a,b   Hennessy, Michael ^b   Eisenberg, Marlene M ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomarkers for HIV AIDS intervention effectiveness; Heath related quality of life; HIV and serious mental illness; Parallell process latent growth curve modeling; Structural equation modeling; Syndemic illness

Indexed keywords

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; COMMUNITY CARE; COMPLICATION; CONTROLLED STUDY; COOPERATION; COST BENEFIT ANALYSIS; COST OF ILLNESS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HOME CARE; HUMAN; LONGITUDINAL STUDY; MALE; MEDICATION COMPLIANCE; MENTAL DISORDERS; MIDDLE AGED; NURSING; ORGANIZATION AND MANAGEMENT; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMMUNITY HEALTH SERVICES; COOPERATIVE BEHAVIOR; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FEMALE; HIV INFECTIONS; HOME CARE SERVICES; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES; VIRAL LOAD;

EID: 84897450713     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0606-x     Document Type: Article

References (42)

1. Gottesman I, Groome CS. HIV/AIDS risks as a consequence of schizophrenia. Schizophr Bull. 1997;23(4):675-84.
2. Walkup J, Blank MB, Gonzalez JS, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47:S15-9.
3. Blank MB, Eisenberg MM. HIV and mental illness: opportunities for prevention. Journal of prevention & intervention in the community. J Prev Interv. 2007;33(1-2):1-4.
4. Susser E, Valencia E, Conover S. Prevalence of HIV-infection among psychiatric patients in a New York City men's shelter. Am J Public Health. 1993;83(4):568-70.
5. Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among medicaid recipients. Psychiatric services. 2002;53(7):868-73.
6. Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, Dixon LB, Blow FC. Understanding associations between serious mental illness and HIV among patients in the VA health system. Psychiatr Serv. 2007;58(9):1165-72.
7. Rothbard A, Blank M, Staab J, et al. Previously undetected metabolic syndromes and infectious diseases among psychiatric inpatients. Psychiatr Serv. 2009;60(4):534-7.
8. Parry CD, Blank MB, Pithey AL. Responding to the threat of HIV among persons with mental illness and substance abuse. Curr Opin Psychiatr. 2007;20(3):235-41.
9. Blank MB, Hanrahan NP, Fishbein M, et al. A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness. Psychiatr Serv. 2011;62(11):1318-24.
10. Walkup J, Blank MB, Gonzalez JS, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47:S15-9.
11. Drake RE. Brief history, current status, and future place of assertive community treatment. Am J Orthopsychiatry. 1998;68(2):172-5.
12. Lee AK, Hanrahan NP, Aiken LH, Blank MB. Perceived facilitators and barriers to the implementation of an advanced practice: nursing intervention for HIV regimen adherence among the seriously mentally ill. J Psychiatr Ment Health Nurs. 2006;13(5):626-8.
13. Morgan BD, Rossi AP. Difficult-to-manage HIV/AIDS clients with psychiatric illness and substance abuse problems: a collaborative practice with psychiatric advanced practice nurses. J Assoc Nurses AIDS Care. 2007;18(6):77-84.
14. Kane CF, Blank MB. NPACT: enhancing programs of assertive community treatment for the seriously mentally Ill. Community Ment Health J. 2004;40(6):549-59.
15. Aiken L, Lake E, Semaan S, et al. Nurse practitioner managed care for persons with HIV infection. J Nurs Scholarsh. 1993;25(3):172-7.
16. Battaglioli-DeNero AM. Strategies for improving patient adherence to therapy and longterm patient outcomes. J Assoc Nurses AIDS Care. 2007;18(1 Suppl):S17-22.
17. Collins L, Murphy S, Bierman K. A conceptual framework for adaptive preventive interventions. Prev Sci. 2004;5(3):185-96.
18. Blank MB, Eisenberg MM. Tailored treatment for HIV + persons with mental illness: the intervention cascade. J Acquir Immune Defic Syndr. 2013;63:S44-8.
19. Ware JE Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of Scales and Preliminary Tests of Reliability and Validity. Med Care. 1996;34(3):220-33.
20. Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and Validity of the SF-12 Health Survey among People with Severe Mental Illness. Med Care. 2000;38(11):1141-50.
21. Curran P, Hussong A. Structural equation modeling of repeated measures data: latent curve analysis. In: Moskowitz D, Hershberger S, editors. Modeling intraindividual variability with repeated measures data. Mahwah: Lawrence Erlbaum; 2002. p. 59-85.
22. Curran P, Muthén B. The application of latent curve analysis to testing developmental theories in intervention research. Am J Community Psychol. 1999;27:567-95.
23. Fergus S, Zimmerman M, Caldwell CH. Growth trajectories of sexual risk behavior in adolescence and young adulthood. Am J Public Health. 2007;97:1096-101.
24. Barnes G, Reifman A, Farrell M, Dintcheff B. The effects of parenting on the development of adolescent alcohol misuse: a six-wave latent growth model. J Marriage Family. 2000;62:175-86.
25. Fishbein M, Hennessy M, Kamb M, et al. Using intervention theory to model factors influencing behavior change. Project RESPECT. Eval Health Prof. 2001;24(4):363-84.
26. Bollen K, Curran P. Latent curve models. New York: Wiley; 2006.
27. Cheong J, MacKinnon DP, Khoo ST. Investigation of mediational processes using parallel process latent growth curve modeling. Struct Equ Modeling. 2003;10(2):238-62.
28. Biesanz J, Deeb-Sossa N, Papadakis A, Bollen K, Curran P. The role of coding time in estimating and interpreting growth curve models. Psychol Methods. 2004;9(1):30-52.
29. Hu L-T, Bentler P. Evaluating model fit. In: Hoyle R, editor. Structural equation modeling: Concepts, issues and applications. Newbury Park: Sage; 1995. p. 76-99.
30. Koblin B, Chesney M, Coates T. Effects of a behavioral intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomized controlled study. Lancet. 2004;364:41-50.
31. Belcher L, Kalichman S, Topping M, et al. A randomized trial of a brief HIV risk reduction counseling intervention for women. J Consult Clin Psychol. 1998;66(5):856-61.
32. Cottler L, Compton W, Abdahllah A, Cunningham-Williams R, Abram F, Fichtenbaum C. Peer delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public Health Rep. 1998;113:58-66.
33. Stephens RC, Simpson DD, Coyle SL, McCoy CB. Comparative effectiveness of NADR interventions. In: Brown BS, Beschner GM, editors. Handbook on risk of AIDS. Westport: Greenwood Press; 1993. p. 519-56.
34. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol. 1995;142(8):864-74.
35. Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users. AIDS. 1998;12(8):919-29.
36. Coyle S, Needle R, Normand J. Outreach based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep. 1998;113(Supplement 1):19-30.
37. Lightfoot M, Rotheram-Borus MJ, Comulada S, Gundersen G, Reddy V. Self-monitoring of behaviour as a risk reduction strategy for persons living with HIV. AIDS Care. 2007;19(6):757-63.
38. Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention: results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43:S41-7.
39. Holzemer WL, Bakken S, Portillo CG. Testing a nurse-tailored HIV medication adherence intervention. Nurs Res. 2006;55:189-97.
40. Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol. 2009;5:143.
41. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-20.
42. Marziali M, De Santis W, Carello R, et al. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. AIDS. 2006;20(16):2033-41.